Livasil

Silymarin (Milk thistle) is indicated for the treatment and prevention of-

• Liver disease, (non-alcoholic & alcoholic)
• Liver cirrhosis, (non-alcoholic & alcoholic)
• Infectious hepatitis
• Drug-induced hepatitis
• Liver disease secondary to diabetes mellitus
• Toxicity of narcotics
• Fatty liver
• Jaundice

Cholagogues, Cholelitholytics & Hepatic Protectors, Herbal and Nutraceuticals

Silymarin, a flavonoid complex of Silybum marianum or Milk thistle, is the biologically active component. It provides hepatocellular protection through toxin blockade at the membrane level, enhances protein synthesis, antioxidant activity, anti-fibrotic activity and possible anti-inflammatory or immunomodulating effects.

1 capsule 2 to 3 times daily or as directed by a physician.

Well tolerated in the recommended dose. Occasionally a mild laxative effect may observe.

Contraindicated in patient with a known hypersensitivity to silymarin.

Concomitant use of silymarin and butyrophenones or phenothiazines has resulted in the reduction of lipid peroxidation.

No experience is available about the use of Silymarin 70 mg or 140 mg during pregnancy and lactation. Therefore, if needed Silymarin 70 mg or 140 mg should be taken with caution according to the physician’s advice.

Store in a cool & dry place, away from light & moisture. Keep out of reach of children.